Dinamiche determinanti del settore farmaceutico in Europa

Francesco Saverio Mennini, Fabrizio Gianfrate and Federico Spandonaro

L'industria, 2005, issue 1, 103-118

Abstract: There is a wide consensus among scholars of the pharmaceutical sector that the American pharmaceutical sector has been much more dynamic and successful than the European one from the mid-1990s onward. The aim of this paper is to reconsider the statistical limelights commonly adopted to justify the present "competitive superiority" of the American pharmaceutical sector, in the light of the policy address of the European pharmaceutical sector. An additional aim is to evaluate what could be the future development of the US and the EU markets using an integrated vision (taking industrial policies, the welfare systems and regulatory policies into account). A particular attention is put on the analysis of the different trends within the European pharmaceutical sector, in order to verify if important signals in terms of new conditions for the European market itself do exist. Some mid-term scenarios are then outlined, evaluating both their consequences and their feasibility.

Date: 2005
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.rivisteweb.it/download/article/10.1430/19610 (application/pdf)
https://www.rivisteweb.it/doi/10.1430/19610 (text/html)
Access to full text is restricted to subscribers

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:mul:j0hje1:doi:10.1430/19610:y:2005:i:1:p:103-118

Access Statistics for this article

L'industria is currently edited by Patrizio Bianchi

More articles in L'industria from Società editrice il Mulino
Bibliographic data for series maintained by ().